🧠 Parkinson's Digest Give Feedback
  • All
  • Research
  • Trials
  • News
Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States
Trial Phase 4 Completed March 28, 2017
Effect of Food on BIA 6-512 (Trans-resveratrol)
Trial Phase 1 Completed March 28, 2017
Tolerability and Steady-state Pharmacokinetics of BIA 6-512
Trial Phase 1 Completed March 27, 2017
Pharmacokinetics of Rising Single-doses of BIA 6-512 and Their Effect on the Levodopa Pharmacokinetics
Trial Phase 1 Completed March 26, 2017
Tolerability, Safety and Pharmacokinetics of Four Single-doses of BIA 6-512 (Trans-resveratrol) and Their Effect on the Levodopa Pharmacokinetics
Trial Phase 1 Completed March 26, 2017
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06649751 in Parkinson's Disease
Trial Phase 1 Completed March 26, 2017
Respiratory Kinematics of Cough in Healthy Older Adults and Parkinson's Disease
Trial Phase 1 Completed March 23, 2017
Investigational Parkinson's Disease In Patients Not Well Controlled On L-dopa
Trial Phase 3 Completed March 22, 2017
An Open-label Continuation Study Evaluating the Long-term Safety of Extended Release Ropinirole XL (Formerly CR) in Parkinson''s Disease
Trial Phase 3 Completed March 22, 2017
Caffeine as a Therapy for Parkinson's Disease
Trial Phase 3 Completed March 21, 2017
Variable Frequency Stimulation of Subthalamic Nucleus for Freezing of Gait in Parkinson's Disease
Trial Phase 1 Completed March 20, 2017
A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease
Trial Phase 1 Completed March 20, 2017
Singing in Groups for Parkinson's Disease; A Pilot Study of Group Singing Therapy for PD-related Voice/Speech Impairment
Trial N/A Completed March 16, 2017
Dance Exercise as Novel Complementary Therapy for Parkinson's Disease
Trial N/A Completed March 15, 2017
Extended Long-Term Safety Study of KW-6500
Trial Phase 3 Completed March 14, 2017
Long-Term Safety Study of KW-6500 in Patients With Parkinson's Disease
Trial Phase 3 Completed March 14, 2017
Safety and Efficacy of botulinumA Toxin (BotoxA) for Treatment of Neurogenic Bladder of Parkinson's Disease
Trial Phase 4 Completed March 9, 2017
Translation and Validation of BELA-p-K for QoL Evaluation in PD Patients
Trial N/A Completed March 7, 2017
Placebo-Controlled Double-Blind Crossover Comparative Study of KW-6500
Trial Phase 3 Completed March 2, 2017
Motor, Non-motor and Genetic Determinants of Progression in Parkinson's Disease: A Mexican Multicenter Cohort Study
Trial N/A Completed March 2, 2017
Previous Next

Parkinson's Digest provides access to the latest Parkinson's disease news, research, and clinical trials.

Feedback | Privacy Policy | Source Code

Created by Brian Gaudino. Data sourced from ClinicalTrials.gov, PubMed, and other public sources.

Parkinson's Digest is provided for informational and educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding medical decisions.

© 2026 Parkinson's Digest